Pfizer Agrees to Settle Zantac Cancer Lawsuits for $250 Million
Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines,1 has agreed to pay between $200 to $250 million to settle more than 10,000 lawsuits filed in the United States related to cancer risks associated with its over-the-counter heartburn drug Zantac (also known as ranitidine). The acid reflux drug was discontinued in […]